cyclosporine has been researched along with Bone Marrow Diseases in 26 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (19.23) | 18.2507 |
| 2000's | 7 (26.92) | 29.6817 |
| 2010's | 13 (50.00) | 24.3611 |
| 2020's | 1 (3.85) | 2.80 |
| Authors | Studies |
|---|---|
| Al-Samkari, H; Park, AK; Park, JC | 1 |
| Ichikawa, T; Kishida, D; Otuki, T; Sekijima, Y; Shimojima, Y; Ueno, KI | 1 |
| Babushok, DV; Olson, T; Peslak, SA | 1 |
| Jain, N; Maiti, A; Oo, TH; Patel, KP; Popat, U; Short, NJ; Simkins, A | 1 |
| Arranto, C; Baldomero, H; Gerull, S; Halter, JP; Heim, D; Kleber, M; Medinger, M; Passweg, JR; Soltermann, Y | 1 |
| Baek, SW; Han, HS; Kim, HK; Kwon, J; Lee, KH; Park, HS; Son, B; Yang, Y | 1 |
| Barrett, J; Childs, RW; Cook, L; Donohue, T; Geller, N; Khuu, H; Kurlander, R; Leitman, S; Pantin, J; Ramos, C; Shah, AA; Stroncek, D; Tian, X; Young, NS | 1 |
| Kulasekararaj, AG; Marsh, JC | 1 |
| Exton, LS; Kirby, B; Mohd Mustapa, MF; Smith, CH; Warren, RB; Weatherhead, SC; Yesudian, PD | 1 |
| Baek, JH; Kim, H; Kim, MY; Lee, EH; Min, YJ; Noh, EK; Park, JH; Shin, SJ | 1 |
| Du, X; Gu, X; Hao, F; Li, C; Li, H; Ma, J; Song, Y; Zhang, S; Zhang, Z | 1 |
| Andersen, LS; Ejbjerg, BJ; Ellingsen, T; Hansen, I; Hetland, ML; Hørslev-Petersen, K; Jacobsen, S; Junker, P; Jurik, AG; Lauridsen, UB; Lindegaard, H; Lottenburger, T; Pedersen, JK; Pødenphant, J; Stengaard-Pedersen, K; Svendsen, A; Tarp, U; Vestergaard, A; Østergaard, M | 1 |
| Risitano, AM | 2 |
| Akahane, D; Asano, N; Ichikawa, N; Kobayashi, H; Sato, K; Shimizu, I; Sumi, M; Ueki, T; Ueno, M; Watanabe, M | 1 |
| Ertorer, ME; Gokcel, A; Kocak, R; Savaş, L | 1 |
| Adkins, D; Blum, W; Brown, R; Chohan, R; Devine, S; DiPersio, JF; Goodnough, LT; Graubert, T; Khoury, H; Tomasson, M; Vij, R | 1 |
| De Carlis, LG; De Gasperi, A; Mancini, V; Marbello, L; Morra, E; Muti, G; Nosari, A | 1 |
| Domański, L; Droździk, M; Dziewanowski, K; Gawrońska-Szklarz, B; Kurzawski, M | 1 |
| Alonso, A; Arias, M; González Molina, M; Sánchez-Plumed, JA | 1 |
| Bailey, RR; Hughes, TH; Jagose, JT | 1 |
| Ishikawa, S; Kai, T; Maruyama, Y; Noji, H; Saitoh, Y; Shichishima, T | 1 |
| Brown, BW; Fisher, GA; Kaubisch, S; Lum, BL; Sikic, BI | 1 |
| Matsuda, T; Nakao, S; Nitta, M; Saito, M; Sasaki, M; Shiobara, S; Yamaguchi, M; Yasue, S | 1 |
| Frickhofen, N; Herrmann, F; Köchling, G; Lange, W; Lindemann, A; Mertelsmann, RH; Raghavachar, A; Schrezenmeier, H | 1 |
5 review(s) available for cyclosporine and Bone Marrow Diseases
| Article | Year |
|---|---|
Diagnosis and Treatment of Aplastic Anemia.
Topics: Anemia, Aplastic; Bone Marrow Diseases; Bone Marrow Transplantation; Cyclosporine; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppression Therapy; Siblings; Tissue Donors | 2017 |
Management of the refractory aplastic anemia patient: what are the options?
Topics: Adult; Age Factors; Alemtuzumab; Allografts; Anemia, Aplastic; Antibodies, Monoclonal, Humanized; Antilymphocyte Serum; Antineoplastic Agents; Benzoates; Bone Marrow Diseases; Bone Marrow Failure Disorders; Cyclosporine; Disease-Free Survival; Hematopoietic Stem Cell Transplantation; Hemoglobinuria, Paroxysmal; Humans; Hydrazines; Immunosuppression Therapy; Immunosuppressive Agents; Middle Aged; Pyrazoles; Siblings; Survival Rate; Unrelated Donors | 2013 |
Immunosuppressive therapies in the management of immune-mediated marrow failures in adults: where we stand and where we are going.
Topics: Adult; Algorithms; Anemia, Aplastic; Antilymphocyte Serum; Bone Marrow Diseases; Bone Marrow Failure Disorders; Cyclosporine; Hemoglobinuria, Paroxysmal; History, 20th Century; Humans; Immunosuppression Therapy; Immunosuppressive Agents | 2011 |
Immunosuppressive therapies in the management of acquired immune-mediated marrow failures.
Topics: Anemia, Aplastic; Animals; Antilymphocyte Serum; Bone Marrow Diseases; Bone Marrow Failure Disorders; Cyclosporine; Hemoglobinuria, Paroxysmal; Horses; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Rabbits | 2012 |
Sirolimus, the first mTOR inhibitor.
Topics: Angiogenesis Inhibitors; Animals; Apoptosis; Atherosclerosis; Bone Marrow Diseases; Cell Division; Clinical Trials as Topic; Cyclosporine; Graft Rejection; Graft vs Host Disease; Humans; Immunosuppressive Agents; Kidney Diseases; Kidney Transplantation; Lymphocyte Subsets; Mice; Multicenter Studies as Topic; Muscle, Smooth, Vascular; Neoplasms; Postoperative Complications; Sirolimus; TOR Serine-Threonine Kinases; Wound Healing | 2006 |
5 trial(s) available for cyclosporine and Bone Marrow Diseases
| Article | Year |
|---|---|
Rapid donor T-cell engraftment increases the risk of chronic graft-versus-host disease following salvage allogeneic peripheral blood hematopoietic cell transplantation for bone marrow failure syndromes.
Topics: Adult; Aged; Anemia, Aplastic; Antilymphocyte Serum; Antineoplastic Agents; Bone Marrow Diseases; Bone Marrow Failure Disorders; Child; Chronic Disease; Cyclosporine; Female; Graft Rejection; Graft vs Host Disease; Granulocyte Colony-Stimulating Factor; Hemoglobinuria, Paroxysmal; Humans; Immunosuppressive Agents; Male; Middle Aged; Mycophenolic Acid; Peripheral Blood Stem Cell Transplantation; Risk Factors; Salvage Therapy; T-Lymphocytes; Time Factors; Transplantation Conditioning; Transplantation, Homologous; Vidarabine; Young Adult | 2013 |
A pilot dose-escalating study of alemtuzumab plus cyclosporine for patients with bone marrow failure syndrome.
Topics: Adolescent; Adult; Aged; Alemtuzumab; Anemia, Aplastic; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Bone Marrow Diseases; Cyclosporine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Myelodysplastic Syndromes; Pilot Projects; Red-Cell Aplasia, Pure; Survival Rate; Treatment Outcome; Young Adult | 2009 |
Radiographic progression and remission rates in early rheumatoid arthritis - MRI bone oedema and anti-CCP predicted radiographic progression in the 5-year extension of the double-blind randomised CIMESTRA trial.
Topics: Adult; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Autoantibodies; Biomarkers; Bone Marrow Diseases; Cyclosporine; Disease Progression; Drug Therapy, Combination; Edema; Epidemiologic Methods; Female; Humans; Immunosuppressive Agents; Magnetic Resonance Imaging; Male; Methotrexate; Middle Aged; Peptides, Cyclic; Prognosis; Radiography; Remission Induction | 2010 |
The impact of thiopurine s-methyltransferase polymorphism on azathioprine-induced myelotoxicity in renal transplant recipients.
Topics: Adolescent; Adult; Aged; Alleles; Azathioprine; Bone Marrow Diseases; Child; Cyclosporine; Dose-Response Relationship, Drug; Female; Gene Frequency; Genotype; Graft Rejection; Hematologic Tests; Humans; Immunosuppressive Agents; Kidney Transplantation; Leukopenia; Male; Methyltransferases; Polymorphism, Genetic; Prednisone; Time Factors | 2005 |
Effect of high-dose cyclosporine on etoposide pharmacodynamics in a trial to reverse P-glycoprotein (MDR1 gene) mediated drug resistance.
Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Area Under Curve; Bone Marrow Diseases; Chromatography, High Pressure Liquid; Cyclosporine; Drug Resistance, Neoplasm; Erythroid Precursor Cells; Etoposide; Female; Genes, MDR; Humans; Immunosuppressive Agents; Infusions, Intravenous; Leukocyte Count; Leukopenia; Male; Middle Aged | 2000 |
16 other study(ies) available for cyclosporine and Bone Marrow Diseases
| Article | Year |
|---|---|
Pembrolizumab-Induced Acquired Amegakaryocytic Thrombocytopenia and Successful Combination Treatment With Eltrombopag, Romiplostim and Cyclosporine: A Brief Communication.
Topics: Antibodies, Monoclonal, Humanized; Benzoates; Bone Marrow Diseases; Communication; Cyclosporine; Humans; Hydrazines; Purpura, Thrombocytopenic; Pyrazoles; Receptors, Fc; Recombinant Fusion Proteins; Thrombopoietin | 2022 |
Acquired Amegakaryocytic Thrombocytopenia in Adult-onset Still's Disease: Successful Combination Therapy with Tocilizumab and Cyclosporine.
Topics: Aged; Antibodies, Monoclonal, Humanized; Bone Marrow Diseases; Combined Modality Therapy; Cyclosporine; Female; Humans; Immunosuppressive Agents; Methotrexate; Prednisolone; Purpura, Thrombocytopenic; Still's Disease, Adult-Onset; Tacrolimus | 2019 |
Acquired amegakaryocytic thrombocytopenia and red cell aplasia in a patient with thymoma progressing to aplastic anemia successfully treated with allogenic stem cell transplantation.
Topics: Anemia, Aplastic; Antilymphocyte Serum; Bone Marrow Diseases; Cyclosporine; Female; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppression Therapy; Middle Aged; Prednisolone; Purpura, Thrombocytopenic; Red-Cell Aplasia, Pure; Thymoma; Thymus Neoplasms | 2019 |
Reduced dose of post-transplantation cyclophosphamide compared to ATG for graft-versus-host disease prophylaxis in recipients of mismatched unrelated donor hematopoietic cell transplantation: a single-center study.
Topics: Adult; Aged; Anemia, Aplastic; Antilymphocyte Serum; Bone Marrow Diseases; Bone Marrow Failure Disorders; Cyclophosphamide; Cyclosporine; Drug Evaluation; Female; Graft Survival; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Hemoglobinuria, Paroxysmal; Histocompatibility; HLA Antigens; Humans; Immunosuppressive Agents; Incidence; Male; Middle Aged; Mycophenolic Acid; Neoplasms; Retrospective Studies; T-Lymphocytes; Tissue Donors | 2019 |
A Case of Acquired Amegakaryocytic Thrombocytopenia with Anti-c-mpl Autoantibody: Comparison with Idiopathic Thrombocytopenic Purpura.
Topics: Autoantibodies; Bone Marrow Cells; Bone Marrow Diseases; Cyclosporine; Female; Gastrointestinal Hemorrhage; Humans; Immunoglobulins, Intravenous; Megakaryocytes; Methylprednisolone; Middle Aged; Platelet Count; Purpura, Thrombocytopenic; Receptors, Thrombopoietin | 2019 |
British Association of Dermatologists' guidelines for the safe and effective prescribing of methotrexate for skin disease 2016.
Topics: Adult; Alcohol Drinking; Biological Products; Bone Marrow Diseases; Checklist; Chemical and Drug Induced Liver Injury; Chickenpox; Child; Counseling; Cyclosporine; Dermatologic Agents; Drug Administration Routes; Drug Administration Schedule; Drug Approval; Drug Interactions; Drug Monitoring; Drug Overdose; Evidence-Based Medicine; Female; Hepatitis, Viral, Human; HIV Infections; Humans; Intraoperative Complications; Kidney Diseases; Lung Diseases; Methotrexate; Nausea; Neoplasms; Off-Label Use; Patient Education as Topic; Patient Safety; Pregnancy; Pregnancy Complications; Retinoids; Skin Diseases; Tuberculosis; Ultraviolet Rays; Vaccination | 2016 |
Immunosuppressive therapy of cyclosporin A for severe benzene-induced haematopoietic disorders and a 6-month follow-up.
Topics: Adolescent; Adult; Anemia, Aplastic; Benzene; Bone Marrow Diseases; Cyclosporine; Female; Follow-Up Studies; Hematologic Tests; Humans; Immunosuppressive Agents; Myelodysplastic Syndromes; Occupational Exposure; Testosterone; Young Adult | 2010 |
Epstein-Barr virus-associated lymphoproliferative disorder developed after anti-thymocyte globulin therapy in a patient with bone marrow failure associated with T-cell large granular lymphocytic leukemia.
Topics: Aged; Anemia, Aplastic; Antilymphocyte Serum; Bone Marrow; Bone Marrow Diseases; Bone Marrow Failure Disorders; Cyclosporine; Epstein-Barr Virus Infections; Fatal Outcome; Hemoglobinuria, Paroxysmal; Herpesvirus 4, Human; Humans; Immunosuppressive Agents; Leukemia, Large Granular Lymphocytic; Lymphoproliferative Disorders; Male; Multiple Organ Failure | 2011 |
Ticlopidine-induced marrow aplasia treated with cyclosporine.
Topics: Bone Marrow Diseases; Cyclosporine; Diabetes Complications; Diabetes Mellitus; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Ticlopidine; Treatment Outcome | 2002 |
Long-term outcomes of allogeneic stem cell transplant recipients after calcineurin inhibitor-induced neurotoxicity.
Topics: Adult; Bone Marrow Diseases; Bone Marrow Transplantation; Brain; Calcineurin Inhibitors; Central Nervous System Diseases; Cyclosporine; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Magnetic Resonance Imaging; Male; Methotrexate; Middle Aged; Prednisone; Retrospective Studies; Tacrolimus; Transplantation, Homologous | 2003 |
Bone marrow hypoplasia complicating tacrolimus (FK506) therapy.
Topics: Adolescent; Bone Marrow Diseases; Chemical and Drug Induced Liver Injury; Cyclosporine; Female; Humans; Immunosuppressive Agents; Liver Transplantation; N-Methyl-3,4-methylenedioxyamphetamine; Tacrolimus | 2004 |
[A new indication for Sandimmum (cyclosporine A). Press release from Sandoz Laboratories].
Topics: Bone Marrow Diseases; Cyclosporine; Humans | 1995 |
Acute bone-marrow oedema in cyclosporin-treated renal transplant recipients.
Topics: Adolescent; Adult; Aged; Bone Marrow Diseases; Cyclosporine; Edema; Female; Humans; Immunosuppressive Agents; Kidney Transplantation; Magnetic Resonance Imaging; Male; Middle Aged; Pain; Radionuclide Imaging; Time Factors | 1997 |
[Effective treatment combining antithymocyte globulin, cyclosporin A, and granulocyte colony-stimulating factor for atypical paroxysmal nocturnal hemoglobinuria accompanied by bone marrow hypoplasia].
Topics: Adult; Antilymphocyte Serum; Bone Marrow Diseases; Cyclosporine; Drug Therapy, Combination; Granulocyte Colony-Stimulating Factor; Hemoglobinuria, Paroxysmal; Humans; Immunosuppressive Agents; Male; Treatment Outcome | 1999 |
HLA-DR2 predicts a favorable response to cyclosporine therapy in patients with bone marrow failure.
Topics: Bone Marrow Diseases; Cyclosporine; HLA-DR2 Antigen | 1992 |
Medullary histiocytosis following treatment of severe aplastic anemia with recombinant human interleukin-3 in combination with antilymphocyte globulin, cyclosporin A, and methylprednisolone.
Topics: Adult; Anemia, Aplastic; Antilymphocyte Serum; Bone Marrow Diseases; Cyclosporine; Drug Therapy, Combination; Histiocytosis; Humans; Interleukin-3; Male; Methylprednisolone; Recombinant Proteins | 1991 |